Period

Intervention

Control

p-value

Existence

Non-existence

Existence

Non-existence

Arrhythmia

Baseline

12 (24.5%)

37 (75.5%)

11 (23.4%)

36 (76.6%)

1.000

3 months

12 (24.5%)

37 (75.5%)

12 (25.5%)

35 (74.5%)

1.000

6 months

11 (22.4%)

38 (77.6%)

12 (25.5%)

35 (74.5%)

0.813

9 months

13 (26.5%)

36 (73.5%)

15 (31.9%)

32 (68.1%)

0.655

12 months

13 (27.7%)

34 (72.3%)

13 (27.7%)

34 (72.3%)

1.000

24 months

10 (24.4%)

31 (75.6%)

-

-

-

36 months

9 (25.0%)

27 (75.0%)

-

-

-

Coughing at night

Baseline

0 (0%)

49 (100%)

0 (0%)

47 (100%)

-

3 months

0 (0%)

49 (100%)

0 (0%)

47 (100%)

-

6 months

0 (0%)

49 (100%)

0 (0%)

47 (100%)

-

9 months

0 (0%)

49 (100%)

0 (0%)

47 (100%)

-

12 months

0 (0%)

47 (100%)

0 (0%)

47 (100%)

-

24 months

0 (0%)

41 (100%)

-

-

-

36 months

0 (0%)

36 (100%)

-

-

-

Moist rale

Baseline

0 (0%)

49 (100%)

0 (0%)

47 (100%)

-

3 months

0 (0%)

49 (100%)

0 (0%)

47 (100%)

-

6 months

0 (0%)

49 (100%)

0 (0%)

47 (100%)

-

9 months

1 (2.0%)

48 (98.0%)

1 (2.1%)

46 (97.9%)

1.000

12 months

0 (0%)

47 (100%)

1 (2.1%)

46 (97.9%)

1.000

24 months

1 (2.4%)

40 (97.6%)

-

-

-

36 months

0 (0%)

36 (100%)

-

-

-

Ankle edema

Baseline

3 (6.1%)

46 (93.9%)

0 (0%)

47 (100%)

0.242

3 months

5 (10.2%)

44 (89.8%)

0 (0%)

47 (100%)

0.056

6 months

2 (4.1%)

47 (95.9%)

1 (2.1%)

46 (97.9%)

1.000

9 months

2 (4.1%)

47 (95.9%)

2 (4.3%)

45 (95.7%)

1.000

12 months

1 (2.1%)

46 (97.9%)

2 (4.3%)

45 (95.7%)

1.000

24 months

2 (4.9%)

39 (95.1%)

-

-

-

36 months

0 (0%)

36 (100%)

-

-

-

Shortness of breath

Baseline

5 (10.2%)

44 (89.8%)

7 (12.8%)

41 (87.2%)

0.757

3 months

3 (6.1%)

46 (93.9%)

10 (21.3%)

37 (78.7%)

0.038*

6 months

5 (10.2%)

44 (89.8%)

11 (23.4%)

36 (76.6%)

0.104

9 months

3 (6.1%)

46 (93.9%)

12 (25.5%)

35 (74.5%)

0.011*

12 months

3 (6.4%)

44 (93.6%)

11 (23.4%)

36 (76.6%)

0.041*

24 months

3 (7.3%)

38 (92.7%)

-

-

-

36 months

5 (13.9%)

31 (86.1%)

-

-

-